<!DOCTYPE html>
<!--
==============================================================================
           "GitHub HTML5 Pandoc Template" v2.1 — by Tristano Ajmone           
==============================================================================
Copyright © Tristano Ajmone, 2017, MIT License (MIT). Project's home:

- https://github.com/tajmone/pandoc-goodies

The CSS in this template reuses source code taken from the following projects:

- GitHub Markdown CSS: Copyright © Sindre Sorhus, MIT License (MIT):
  https://github.com/sindresorhus/github-markdown-css

- Primer CSS: Copyright © 2016-2017 GitHub Inc., MIT License (MIT):
  http://primercss.io/

~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~
The MIT License 

Copyright (c) Tristano Ajmone, 2017 (github.com/tajmone/pandoc-goodies)
Copyright (c) Sindre Sorhus <sindresorhus@gmail.com> (sindresorhus.com)
Copyright (c) 2017 GitHub Inc.

"GitHub Pandoc HTML5 Template" is Copyright (c) Tristano Ajmone, 2017, released
under the MIT License (MIT); it contains readaptations of substantial portions
of the following third party softwares:

(1) "GitHub Markdown CSS", Copyright (c) Sindre Sorhus, MIT License (MIT).
(2) "Primer CSS", Copyright (c) 2016 GitHub Inc., MIT License (MIT).

Permission is hereby granted, free of charge, to any person obtaining a copy
of this software and associated documentation files (the "Software"), to deal
in the Software without restriction, including without limitation the rights
to use, copy, modify, merge, publish, distribute, sublicense, and/or sell
copies of the Software, and to permit persons to whom the Software is
furnished to do so, subject to the following conditions:

The above copyright notice and this permission notice shall be included in all
copies or substantial portions of the Software.

THE SOFTWARE IS PROVIDED "AS IS", WITHOUT WARRANTY OF ANY KIND, EXPRESS OR
IMPLIED, INCLUDING BUT NOT LIMITED TO THE WARRANTIES OF MERCHANTABILITY,
FITNESS FOR A PARTICULAR PURPOSE AND NONINFRINGEMENT. IN NO EVENT SHALL THE
AUTHORS OR COPYRIGHT HOLDERS BE LIABLE FOR ANY CLAIM, DAMAGES OR OTHER
LIABILITY, WHETHER IN AN ACTION OF CONTRACT, TORT OR OTHERWISE, ARISING FROM,
OUT OF OR IN CONNECTION WITH THE SOFTWARE OR THE USE OR OTHER DEALINGS IN THE
SOFTWARE.
==============================================================================-->
<html>
<head>
  <meta charset="utf-8" />
  <meta name="generator" content="pandoc" />
  <meta name="viewport" content="width=device-width, initial-scale=1.0, user-scalable=yes" />
  <title>Scabies  MeG-CLS-066</title>
  <style type="text/css">
@charset "UTF-8";.markdown-body{-ms-text-size-adjust:100%;-webkit-text-size-adjust:100%;color:#24292e;font-family:-apple-system,system-ui,BlinkMacSystemFont,"Segoe UI",Helvetica,Arial,sans-serif,"Apple Color Emoji","Segoe UI Emoji","Segoe UI Symbol";font-size:16px;line-height:1.5;word-wrap:break-word;box-sizing:border-box;min-width:200px;max-width:980px;margin:0 auto;padding:45px}.markdown-body a{color:#0366d6;background-color:transparent;text-decoration:none;-webkit-text-decoration-skip:objects}.markdown-body a:active,.markdown-body a:hover{outline-width:0}.markdown-body a:hover{text-decoration:underline}.markdown-body a:not([href]){color:inherit;text-decoration:none}.markdown-body strong{font-weight:600}.markdown-body h1,.markdown-body h2,.markdown-body h3,.markdown-body h4,.markdown-body h5,.markdown-body h6{margin-top:24px;margin-bottom:16px;font-weight:600;line-height:1.25}.markdown-body h1{font-size:2em;margin:.67em 0;padding-bottom:.3em;border-bottom:1px solid #eaecef}.markdown-body h2{padding-bottom:.3em;font-size:1.5em;border-bottom:1px solid #eaecef}.markdown-body h3{font-size:1.25em}.markdown-body h4{font-size:1em}.markdown-body h5{font-size:.875em}.markdown-body h6{font-size:.85em;color:#6a737d}.markdown-body img{border-style:none}.markdown-body svg:not(:root){overflow:hidden}.markdown-body hr{box-sizing:content-box;height:.25em;margin:24px 0;padding:0;overflow:hidden;background-color:#e1e4e8;border:0}.markdown-body hr::before{display:table;content:""}.markdown-body hr::after{display:table;clear:both;content:""}.markdown-body input{margin:0;overflow:visible;font:inherit;font-family:inherit;font-size:inherit;line-height:inherit}.markdown-body [type=checkbox]{box-sizing:border-box;padding:0}.markdown-body *{box-sizing:border-box}.markdown-body blockquote{margin:0}.markdown-body ol,.markdown-body ul{padding-left:2em}.markdown-body ol ol,.markdown-body ul ol{list-style-type:lower-roman}.markdown-body ol ol,.markdown-body ol ul,.markdown-body ul ol,.markdown-body ul ul{margin-top:0;margin-bottom:0}.markdown-body ol ol ol,.markdown-body ol ul ol,.markdown-body ul ol ol,.markdown-body ul ul ol{list-style-type:lower-alpha}.markdown-body li>p{margin-top:16px}.markdown-body li+li{margin-top:.25em}.markdown-body dd{margin-left:0}.markdown-body dl{padding:0}.markdown-body dl dt{padding:0;margin-top:16px;font-size:1em;font-style:italic;font-weight:600}.markdown-body dl dd{padding:0 16px;margin-bottom:16px}.markdown-body code{font-family:SFMono-Regular,Consolas,"Liberation Mono",Menlo,Courier,monospace}.markdown-body pre{font:12px SFMono-Regular,Consolas,"Liberation Mono",Menlo,Courier,monospace;word-wrap:normal}.markdown-body blockquote,.markdown-body dl,.markdown-body ol,.markdown-body p,.markdown-body pre,.markdown-body table,.markdown-body ul{margin-top:0;margin-bottom:16px}.markdown-body blockquote{padding:0 1em;color:#6a737d;border-left:.25em solid #dfe2e5}.markdown-body blockquote>:first-child{margin-top:0}.markdown-body blockquote>:last-child{margin-bottom:0}.markdown-body table{display:block;width:100%;overflow:auto;border-spacing:0;border-collapse:collapse}.markdown-body table th{font-weight:600}.markdown-body table td,.markdown-body table th{padding:6px 13px;border:1px solid #dfe2e5}.markdown-body table tr{background-color:#fff;border-top:1px solid #c6cbd1}.markdown-body table tr:nth-child(2n){background-color:#f6f8fa}.markdown-body img{max-width:100%;box-sizing:content-box;background-color:#fff}.markdown-body code{padding:.2em 0;margin:0;font-size:85%;background-color:rgba(27,31,35,.05);border-radius:3px}.markdown-body code::after,.markdown-body code::before{letter-spacing:-.2em;content:" "}.markdown-body pre>code{padding:0;margin:0;font-size:100%;word-break:normal;white-space:pre;background:0 0;border:0}.markdown-body .highlight{margin-bottom:16px}.markdown-body .highlight pre{margin-bottom:0;word-break:normal}.markdown-body .highlight pre,.markdown-body pre{padding:16px;overflow:auto;font-size:85%;line-height:1.45;background-color:#f6f8fa;border-radius:3px}.markdown-body pre code{display:inline;max-width:auto;padding:0;margin:0;overflow:visible;line-height:inherit;word-wrap:normal;background-color:transparent;border:0}.markdown-body pre code::after,.markdown-body pre code::before{content:normal}.markdown-body .full-commit .btn-outline:not(:disabled):hover{color:#005cc5;border-color:#005cc5}.markdown-body kbd{box-shadow:inset 0 -1px 0 #959da5;display:inline-block;padding:3px 5px;font:11px/10px SFMono-Regular,Consolas,"Liberation Mono",Menlo,Courier,monospace;color:#444d56;vertical-align:middle;background-color:#fcfcfc;border:1px solid #c6cbd1;border-bottom-color:#959da5;border-radius:3px;box-shadow:inset 0 -1px 0 #959da5}.markdown-body :checked+.radio-label{position:relative;z-index:1;border-color:#0366d6}.markdown-body .task-list-item{list-style-type:none}.markdown-body .task-list-item+.task-list-item{margin-top:3px}.markdown-body .task-list-item input{margin:0 .2em .25em -1.6em;vertical-align:middle}.markdown-body::before{display:table;content:""}.markdown-body::after{display:table;clear:both;content:""}.markdown-body>:first-child{margin-top:0!important}.markdown-body>:last-child{margin-bottom:0!important}.Alert,.Error,.Note,.Success,.Warning{padding:11px;margin-bottom:24px;border-style:solid;border-width:1px;border-radius:4px}.Alert p,.Error p,.Note p,.Success p,.Warning p{margin-top:0}.Alert p:last-child,.Error p:last-child,.Note p:last-child,.Success p:last-child,.Warning p:last-child{margin-bottom:0}.Alert{color:#246;background-color:#e2eef9;border-color:#bac6d3}.Warning{color:#4c4a42;background-color:#fff9ea;border-color:#dfd8c2}.Error{color:#911;background-color:#fcdede;border-color:#d2b2b2}.Success{color:#22662c;background-color:#e2f9e5;border-color:#bad3be}.Note{color:#2f363d;background-color:#f6f8fa;border-color:#d5d8da}.Alert h1,.Alert h2,.Alert h3,.Alert h4,.Alert h5,.Alert h6{color:#246;margin-bottom:0}.Warning h1,.Warning h2,.Warning h3,.Warning h4,.Warning h5,.Warning h6{color:#4c4a42;margin-bottom:0}.Error h1,.Error h2,.Error h3,.Error h4,.Error h5,.Error h6{color:#911;margin-bottom:0}.Success h1,.Success h2,.Success h3,.Success h4,.Success h5,.Success h6{color:#22662c;margin-bottom:0}.Note h1,.Note h2,.Note h3,.Note h4,.Note h5,.Note h6{color:#2f363d;margin-bottom:0}.Alert h1:first-child,.Alert h2:first-child,.Alert h3:first-child,.Alert h4:first-child,.Alert h5:first-child,.Alert h6:first-child,.Error h1:first-child,.Error h2:first-child,.Error h3:first-child,.Error h4:first-child,.Error h5:first-child,.Error h6:first-child,.Note h1:first-child,.Note h2:first-child,.Note h3:first-child,.Note h4:first-child,.Note h5:first-child,.Note h6:first-child,.Success h1:first-child,.Success h2:first-child,.Success h3:first-child,.Success h4:first-child,.Success h5:first-child,.Success h6:first-child,.Warning h1:first-child,.Warning h2:first-child,.Warning h3:first-child,.Warning h4:first-child,.Warning h5:first-child,.Warning h6:first-child{margin-top:0}h1.title,p.subtitle{text-align:center}h1.title.followed-by-subtitle{margin-bottom:0}p.subtitle{font-size:1.5em;font-weight:600;line-height:1.25;margin-top:0;margin-bottom:16px;padding-bottom:.3em}div.line-block{white-space:pre-line}
  </style>
  <style type="text/css">code{white-space: pre;}</style>
  <!--[if lt IE 9]>
    <script src="//cdnjs.cloudflare.com/ajax/libs/html5shiv/3.7.3/html5shiv-printshiv.min.js"></script>
  <![endif]-->
</head>
<body>
<article class="markdown-body">
<h1 id="scabies">Scabies</h1>
<h2 id="executive-summary"><em>Executive summary</em></h2>
<h2 id="introduction">Introduction</h2>
<h2 id="scabies-is-a-cutaneous-infestation-caused-by-the-mite-sarcoptei-scabei-and-usually-affecting-the-extremities.-it-is-transmitted-by-close-cutaneous-contact-sexually-and-by-contact-with-infested-fomites-e.g.-towels-clothing.">Scabies is a cutaneous infestation caused by the mite <em>Sarcoptei scabei</em> and usually affecting the extremities. It is transmitted by close cutaneous contact, sexually, and by contact with infested fomites (e.g. towels, clothing).</h2>
<h3 id="target-user">Target User</h3>
<ul>
<li><div data-custom-style="List Paragraph">
<p>Doctors</p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p>Nurses</p>
</div></li>
</ul>
<h3 id="target-area-of-use">Target area of use </h3>
<p>OPD</p>
<h3 id="key-areas-of-focus-new-additions-changes">Key areas of focus / New additions / Changes </h3>
<p>This guideline focuses on the common types of scabies and their management and recommends use of topical treatment. It also advises on the elimination of the causative mites.</p>
<p>Management of scabies is dependent on the type of scabies the patient presents with and there may be need to add oral medication to the treatment.</p>
<p>It is important that close human contacts and fomites are treated as well as the presenting patient.</p>
<h3 id="limitations">Limitations </h3>
<h2 id="none.">None.</h2>
<h2 id="presenting-symptoms-and-signs">Presenting symptoms and signs</h2>
<p>Presentation is dependent on the immune status of the patient.</p>
<h3 id="classical-scabies">Classical scabies</h3>
<p>Occurs in immunocompetent patients.</p>
<p>Symptoms include:</p>
<ul>
<li><div data-custom-style="List Paragraph">
<p>Erythematous papules located in the interdigital spaces of fingers, periumbilical region, axillary folds, breasts, genitalia, extensor surfaces of limbs. The face, soles and palms are usually spared.</p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p>Pruritus which is worse at night</p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p>There may be signs of secondary bacterial infection</p>
</div></li>
</ul>
<h3 id="crusted-scabies">Crusted scabies</h3>
<p>Occurs in patients who are severely immune-compromised e.g. in HIV, malignancy.</p>
<ul>
<li><div data-custom-style="List Paragraph">
<p>Pruritus is often absent or mild</p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p>Lesions are generalized, consisting of poorly defined fissured plaques covered by crusts and scales</p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p>Secondary bacterial infection may result in malodorous lesions</p>
</div></li>
</ul>
<h2 id="examination-findings">Examination findings</h2>
<p>Examination of affected areas may reveal</p>
<ul>
<li><div data-custom-style="List Paragraph">
<p>Scratch marks</p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p>Papular lesions, which are erythematous, located in areas of predilection</p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p>Fissured plaques covered by crusts and scales</p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p>The burrow (a pathognomonic sign) appearing as a thin, brown-grey elevations in the superficial epidermis usually of 0.5–1 cm in size.</p>
</div></li>
</ul>
<h2 id="differential-diagnoses">Differential diagnoses</h2>
<ul>
<li><div data-custom-style="List Paragraph">
<p>Drug reactions</p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p>Viral exanthem</p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p>Bullous pemphigoid</p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p>Necrotizing vasculitis</p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p>B-cell lymphoma with monoclonal infiltrate</p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p>Dermatologic manifestations of renal disease</p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p>Erythroderma (generalized exfoliative dermatitis)</p>
</div></li>
</ul>
<ul>
<li><div data-custom-style="List Paragraph">
<p>Folliculitis</p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p>Insect bites</p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p>Lice</p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p>Lichen planus</p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p>Neurotic excoriations</p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p>Papular urticaria</p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p>Psoriasis</p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p>Sea bather’s eruption</p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p>Syphilis</p>
</div></li>
</ul>
<h2 id="investigations">Investigations</h2>
<ul>
<li><div data-custom-style="List Paragraph">
<p>Microscopy of skin scrapings to identify mites, eggs or faecal matter.</p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p>STI screen should be done in all sexually active patients</p>
</div></li>
</ul>
<h2 id="management">Management</h2>
<p>All patients diagnosed with scabies should be advised to machine wash all clothing, towels and beddings at 50 degrees Celsius or higher OR to seal all clothing, towels and beddings in a plastic bag for at least 1 week. In our context, leaving all items outside in the hot sun for a full day is also effective.</p>
<h3 id="classical-scabies-1">Classical scabies</h3>
<p>Benzyl benzoate lotion 10–25% applied once daily at night on 2 consecutive days with re-application at 7 days</p>
<p>Topical treatment should be applied to all skin regions including scalp, groin, navel, external genitalia, finger and toe web spaces and the skin beneath the ends of the nails at night, and left for 8–12 h. The skin should be cool and dry. Re-application is recommended after 7–14 days. After applying treatment, patients should change into clean clothing. All the patient’s close personal contacts should be treated simultaneously to avoid re-infestation.</p>
<h3 id="crusted-scabies-1">Crusted scabies</h3>
<p>Benzyl benzoate lotion 10-25% applied once daily on 7 consecutive days, then twice weekly until cured AND oral Ivermectin 200 µg/kg OD on days 1, 2, 8, 9, and 15. Ivermectin should not be used in children &lt; 15 kg and pregnant women.</p>
<p>Follow up visit for microscopy examination should be made 2 weeks after completion of therapy .</p>
<p><strong>References</strong></p>
<p>UpToDate: Management of scabies https://www.uptodate.com/contents/scabies-management?csi=aafa7509-fad8-4d21-89d6-c7bf3b5272d4&amp;source=contentShare</p>
<p>European guideline for the management of scabies C.M. Salavastru et al https://iusti.org/regions/Europe/pdf/2017/Scabies.pdf</p>
<table>
<thead>
<tr class="header">
<th><strong>Written by:</strong></th>
<th>Name: Azeezat Sallahdeen</th>
<th>Date: 24 November 2018</th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td><strong>Reviewed by:</strong></td>
<td>Name: Orighomisan Agboghoroma</td>
<td>Date: 06 December 2018</td>
</tr>
<tr class="even">
<td><strong>Version:</strong></td>
<td><strong>Change history:</strong></td>
<td><strong>Review due date:</strong></td>
</tr>
<tr class="odd">
<td>1.0</td>
<td>New document</td>
<td>31 January 2021</td>
</tr>
<tr class="even">
<td>1.1</td>
<td>Executive summary added</td>
<td>31 January 2021</td>
</tr>
<tr class="odd">
<td>Review Comments (<em>if applicable)</em></td>
<td></td>
<td></td>
</tr>
</tbody>
</table>
</article>
</body>
</html>
